Heat vs. scalpel: new study tests microwave ablation for lung cancer

NCT ID NCT04430725

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two standard treatments for lung tumors: microwave ablation, which uses heat to kill cancer cells, and surgical wedge resection, which removes a small piece of lung. Researchers want to see which method works better and is safer for patients with non-small cell lung cancer, sarcoma, or colorectal cancer that has spread to the lungs. About 74 participants will be followed to track tumor recurrence and side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
microwave ablation
What this could lead to
If this trial succeeds, it could show that microwave ablation is a safe and effective alternative to surgery for certain lung tumors, potentially reducing recovery time.
What could go wrong
This is a relatively small, early-stage study (74 participants) comparing two established procedures. Results may not apply to all patients, and there is a risk of tumor recurrence or side effects from the ablation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.